GluN2A mediates ketamine-induced rapid antidepressant-like responses

[1]  J. Kaminker,et al.  NMDA receptor-dependent prostaglandin-endoperoxide synthase 2 induction in neurons promotes glial proliferation during brain development and injury. , 2022, Cell reports.

[2]  J. Radulovic,et al.  GluN2A-ERK-mTOR pathway confers a vulnerability to LPS-induced depressive-like behaviour , 2021, Behavioural Brain Research.

[3]  C. Zarate,et al.  Novel Glutamatergic Modulators for the Treatment of Mood Disorders: Current Status , 2021, CNS Drugs.

[4]  J. Lacaille,et al.  Antidepressant actions of ketamine engage cell-specific translation via eIF4E , 2020, Nature.

[5]  D. Johnston,et al.  Antidepressant Effects of (S)-Ketamine through a Reduction of Hyperpolarization-Activated Current Ih , 2020, iScience.

[6]  K. Behar,et al.  Cell-type specific modulation of NMDA receptors triggers antidepressant actions , 2020, Molecular Psychiatry.

[7]  S. Wilkinson,et al.  A new generation of antidepressants: an update on the pharmaceutical pipeline for novel and rapid-acting therapeutics in mood disorders based on glutamate/GABA neurotransmitter systems. , 2019, Drug discovery today.

[8]  J. Nyengaard,et al.  Neurite atrophy in dorsal hippocampus of rat indicates incomplete recovery of chronic mild stress induced depression , 2019, NMR in biomedicine.

[9]  N. Picard,et al.  NMDA 2A receptors in parvalbumin cells mediate sex-specific rapid ketamine response on cortical activity , 2019, Molecular Psychiatry.

[10]  T. Gould,et al.  Ketamine and Ketamine Metabolite Pharmacology: Insights into Therapeutic Mechanisms , 2018, Pharmacological Reviews.

[11]  R. Duman.  Ketamine and rapid-acting antidepressants: a new era in the battle against depression and suicide , 2018, F1000Research.

[12]  L. McMahon,et al.  Disinhibition of CA1 pyramidal cells by low-dose ketamine and other antagonists with rapid antidepressant efficacy , 2018, Proceedings of the National Academy of Sciences.

[13]  N. Tamamaki,et al.  Inhibitory neuron‐specific Cre‐dependent red fluorescent labeling using VGAT BAC‐based transgenic mouse lines with identified transgene integration sites , 2018, The Journal of comparative neurology.

[14]  Hailan Hu,et al.  Ketamine blocks bursting in the lateral habenula to rapidly relieve depression , 2018, Nature.

[15]  Hailan Hu,et al.  Astroglial Kir4.1 in the lateral habenula drives neuronal bursts in depression , 2018, Nature.

[16]  D. Inta,et al.  Molecular and cellular dissection of NMDA receptor subtypes as antidepressant targets , 2018, Neuroscience & Biobehavioral Reviews.

[17]  Qiye He,et al.  Use of TAI-FISH to visualize neural ensembles activated by multiple stimuli , 2017, Nature Protocols.

[18]  Guoqiang Hou,et al.  NMDA Receptors Regulate the Development of Neuronal Intrinsic Excitability through Cell-Autonomous Mechanisms , 2017, Front. Cell. Neurosci..

[19]  J. Sato,et al.  The Nucleus Accumbens and Ketamine Treatment in Major Depressive Disorder , 2017, Neuropsychopharmacology.

[20]  Kyle A. Lyman,et al.  HCN channel dendritic targeting requires bipartite interaction with TRIP8b and regulates antidepressant-like behavioral effects , 2016, Molecular Psychiatry.

[21]  Xi-Ping Huang,et al.  NMDAR inhibition-independent antidepressant actions of ketamine metabolites , 2016, Nature.

[22]  W. Lu,et al.  An NMDA Receptor-Dependent Mechanism Underlies Inhibitory Synapse Development. , 2016, Cell reports.

[23]  K. Jiao,et al.  Correlation of functional GRIN2A gene promoter polymorphisms with schizophrenia and serum D-serine levels. , 2015, Gene.

[24]  K. Nakazawa,et al.  NMDA receptor subunits and associated signaling molecules mediating antidepressant-related effects of NMDA-GluN2B antagonism , 2015, Behavioural Brain Research.

[25]  Michele Pignatelli,et al.  Engram cells retain memory under retrograde amnesia , 2015, Science.

[26]  K. Deisseroth,et al.  Ventral hippocampal afferents to the nucleus accumbens regulate susceptibility to depression , 2015, Nature Communications.

[27]  Rachel S White,et al.  Pyramidal Cell Selective Ablation of N-Methyl-D-Aspartate Receptor 1 Causes Increase in Cellular and Network Excitability , 2015, Biological Psychiatry.

[28]  Y. Auberson,et al.  The Role of GluN2A and GluN2B Subunits on the Effects of NMDA Receptor Antagonists in Modeling Schizophrenia and Treating Refractory Depression , 2014, Neuropsychopharmacology.

[29]  J. Kaminker,et al.  Activity-Induced Nr4a1 Regulates Spine Density and Distribution Pattern of Excitatory Synapses in Pyramidal Neurons , 2014, Neuron.

[30]  E. Nestler,et al.  The brain reward circuitry in mood disorders , 2013, Nature Reviews Neuroscience.

[31]  Qiang Zhou,et al.  NMDA receptor subunit diversity: impact on receptor properties, synaptic plasticity and disease , 2013, Nature Reviews Neuroscience.

[32]  Mark Ellisman,et al.  The Cell-Autonomous Role of Excitatory Synaptic Transmission in the Regulation of Neuronal Structure and Function , 2013, Neuron.

[33]  S. Chaki,et al.  Role of BDNF/TrkB signaling in antidepressant-like effects of a group II metabotropic glutamate receptor antagonist in animal models of depression , 2013, Behavioural Brain Research.

[34]  Daisuke Kase,et al.  The Role of HCN Channels on Membrane Excitability in the Nervous System , 2012, Journal of signal transduction.

[35]  D. Johnston,et al.  Enhancement of Dorsal Hippocampal Activity by Knockdown of HCN1 Channels Leads to Anxiolytic- and Antidepressant-like Behaviors , 2012, Neuron.

[36]  D. Malone,et al.  Consequences of early life MK-801 administration: Long-term behavioural effects and relevance to schizophrenia research , 2012, Behavioural Brain Research.

[37]  Linh Vong,et al.  Leptin Action on GABAergic Neurons Prevents Obesity and Reduces Inhibitory Tone to POMC Neurons , 2011, Neuron.

[38]  E. Kavalali,et al.  NMDA Receptor Blockade at Rest Triggers Rapid Behavioural Antidepressant Responses , 2011, Nature.

[39]  Nanxin Li,et al.  mTOR-Dependent Synapse Formation Underlies the Rapid Antidepressant Effects of NMDA Antagonists , 2010, Science.

[40]  Allan R. Jones,et al.  A robust and high-throughput Cre reporting and characterization system for the whole mouse brain , 2009, Nature Neuroscience.

[41]  Naoshige Uchida,et al.  A Defined Network of Fast-Spiking Interneurons in Orbitofrontal Cortex: Responses to Behavioral Contingencies and Ketamine Administration , 2009, Front. Syst. Neurosci..

[42]  J. Mann,et al.  Early evidence on the effects of regulators' suicidality warnings on SSRI prescriptions and suicide in children and adolescents. , 2007, The American journal of psychiatry.

[43]  A. Bhandoola,et al.  Deletion of the developmentally essential gene ATR in adult mice leads to age-related phenotypes and stem cell loss. , 2007, Cell stem cell.

[44]  O. Hermanson,et al.  Genetic targeting of principal neurons in neocortex and hippocampus of NEX‐Cre mice , 2006, Genesis.

[45]  D. Wyllie,et al.  Equilibrium Constants for (R)-[(S)-1-(4-Bromo-phenyl)-ethylamino]-(2,3-dioxo-1,2,3,4-tetrahydroquinoxalin-5-yl)-methyl]-phosphonic Acid (NVP-AAM077) Acting at Recombinant NR1/NR2A and NR1/NR2B N-Methyl-d-aspartate Receptors: Implications for Studies of Synaptic Transmission , 2006, Molecular Pharmacology.

[46]  A. Holmes,et al.  Genetic Inactivation of the NMDA Receptor NR2A Subunit has Anxiolytic- and Antidepressant-Like Effects in Mice , 2006, Neuropsychopharmacology.

[47]  V. Murthy,et al.  Multiple forms of synaptic plasticity triggered by selective suppression of activity in individual neurons , 2002, Nature.

[48]  M. Fava,et al.  Timing of onset of antidepressant response with fluoxetine treatment. , 2000, The American journal of psychiatry.

[49]  D. Kernell,et al.  Input Resistance, Electrical Excitability, and Size of Ventral Horn Cells in Cat Spinal Cord , 1966, Science.